Wide Ranks

CLGN

CollPlant Biotechnologies Ltd.

4.25

Top Statistics
Market Cap 48 M Forward PE -10.89 Revenue Growth -97.60 %
Current Ratio 6.27 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -1.93 Enterprise / Revenue 48.36 Price To Sales Trailing12 Months 70.63
Profitability
Profit Margins 0.00 % Operating Margins -1769.48 %
Balance Sheet
Total Cash 18 M Total Cash Per Share 1.65 Total Debt 3 M
Total Debt To Equity 16.33 Current Ratio 6.27 Book Value Per Share 2.48
All Measures
Short Ratio 70.00 % Message Board Id finmb_25715728 Fax 972 73 232 5602
Shares Short Prior Month 14451 Return On Equity -0.6155 City Rehovot
Uuid be96d14b-47cb-3f24-9d74-c228d77eedc9 Previous Close 4.30 First Trade Date Epoch Utc 1 B
Book Value 2.48 Beta 0.4830 Total Debt 3 M
Volume 21036 Price To Book 1.72 Fifty Two Week Low 3.31
Total Cash Per Share 1.65 Total Revenue 689000 Shares Short Previous Month Date 1 B
Target Median Price 12.50 Max Age 86400 Recommendation Mean 1.50
Sand P52 Week Change 0.3133 Operating Margins -1769.48 % Target Mean Price 12.50
Net Income To Common -17471000 Short Percent Of Float 0.0015 Implied Shares Outstanding 11 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 11890
Average Volume10days 11890 Total Cash 18 M Next Fiscal Year End 1 B
Revenue Per Share 0.0600 Held Percent Insiders 0.1016 Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 4.30
Target Low Price 11.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 4.31
Open 3.55 Free Cashflow 2 M Dividend Yield 0.00 %
Return On Assets -0.3377 Time Zone Short Name EST Trailing Eps -1.53
Day Low 3.51 Address1 Weizmann Science Park Shares Outstanding 11 M
Price Hint 4 Target High Price 14.00 Website https://www.collplant.com
52 Week Change -0.2246 Average Volume 11804 Forward Eps -0.3900
Recommendation Key strong_buy Compensation As Of Epoch Date 1 B Quick Ratio 606.60 %
Is_sp_500 False Regular Market Day High 4.25 Profit Margins 0.00 %
Debt To Equity 16.33 Fifty Two Week High 6.99 Day High 4.25
Shares Short 12072 Regular Market Open 3.55 Industry Key biotechnology
Earnings Growth 0.00 % Enterprise To Revenue 48.36 Revenue Growth -97.60 %
Shares Percent Shares Out 0.0011 Operating Cashflow -2750000 Currency USD
Time Zone Full Name America/New_York Market Cap 48 M Is_nasdaq_100 False
Zip 7670104 Quote Type EQUITY Industry Biotechnology
Long Name CollPlant Biotechnologies Ltd. Regular Market Day Low 3.51 Held Percent Institutions 0.1223
Current Price 4.25 Address2 4 Oppenheimer Enterprise To Ebitda -1.93
Financial Currency USD Current Ratio 6.27 Gross Margins -209.43 %
Industry Disp Biotechnology Number Of Analyst Opinions 2 Country Israel
Float Shares 7 M Two Hundred Day Average 5.01 Enterprise Value 33 M
Price To Sales Trailing12 Months 70.63 Forward PE -10.89 Regular Market Volume 21036
Ebitda -17308000 Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
CollPlant Biotechnologies Ltd.

, a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.

Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology.

The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures.

It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies.

The company was formerly known as CollPlant Holdings Ltd.

and changed its name to CollPlant Biotechnologies Ltd.

in June 2019.

The company was founded in 2004 and is headquartered in Rehovot, Israel.